1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with theobromine in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (theobromine) | Trials (theobromine) | Recent Studies (post-2010) (theobromine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,864 | 174 | 274 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freyburger, G; Hammerschmidt, DE; Huh, PW; Kotasek, D; McCarthy, T; Vercellotti, GM | 1 |
| Becker, BF; Raschke, P | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and theobromine
| Article | Year |
|---|---|
Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
Topics: Blood Platelets; Cell Adhesion; Cell Aggregation; Chemotaxis, Leukocyte; Endothelium, Vascular; Granulocytes; Humans; Pentoxifylline; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Superoxides; Theobromine; Theophylline; Thrombin | 1988 |
Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischaemia.
Topics: Adenosine; Animals; Azepines; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Perfusion; Platelet Activating Factor; Receptors, Purinergic P1; Theobromine; Triazoles; Xanthines | 1995 |